Return On Equity of BioNexus Gene Lab Corp from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioNexus Gene Lab Corp quarterly and annual Return On Equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • BioNexus Gene Lab Corp Return On Equity for the quarter ending 30 Sep 2025 was -30%, a 204% decline year-over-year.
  • BioNexus Gene Lab Corp annual Return On Equity for 2024 was -17%, a 49% increase from 2023.
  • BioNexus Gene Lab Corp annual Return On Equity for 2023 was -34%, a 549% decline from 2022.
  • BioNexus Gene Lab Corp annual Return On Equity for 2022 was -5.3%, a 149% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

BioNexus Gene Lab Corp Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -30% -20% -204% 01 Jul 2025 30 Sep 2025
Q2 2025 -36% -12% -53% 01 Apr 2025 30 Jun 2025
Q1 2025 -24% +7.2% +23% 01 Jan 2025 31 Mar 2025
Q4 2024 -17% +17% +49% 01 Oct 2024 31 Dec 2024
Q3 2024 -9.9% +35% +78% 01 Jul 2024 30 Sep 2024
Q2 2024 -23% -14% -157% 01 Apr 2024 30 Jun 2024
Q1 2024 -31% -25% -364% 01 Jan 2024 31 Mar 2024
Q4 2023 -34% -29% -549% 01 Oct 2023 31 Dec 2023
Q3 2023 -45% -43% -2699% 01 Jul 2023 30 Sep 2023
Q2 2023 -9% -13% -342% 01 Apr 2023 30 Jun 2023
Q1 2023 -6.8% -13% -211% 01 Jan 2023 31 Mar 2023
Q4 2022 -5.3% -16% -149% 01 Oct 2022 31 Dec 2022
Q3 2022 -1.6% -8.7% -122% 01 Jul 2022 30 Sep 2022
Q2 2022 3.7% -2.6% -41% 01 Apr 2022 30 Jun 2022
Q1 2022 6.1% +0.59% +11% 01 Jan 2022 31 Mar 2022
Q4 2021 11% -6.2% -36% 01 Oct 2021 31 Dec 2021
Q3 2021 7.2% -16% -69% 01 Jul 2021 30 Sep 2021
Q2 2021 6.3% -19% -75% 01 Apr 2021 30 Jun 2021
Q1 2021 5.5% -30% -84% 01 Jan 2021 31 Mar 2021
Q4 2020 17% +36% 01 Oct 2020 31 Dec 2020
Q3 2020 23% +42% 01 Jul 2020 30 Sep 2020
Q2 2020 25% 01 Apr 2020 30 Jun 2020
Q1 2020 36% 01 Jan 2020 31 Mar 2020
Q4 2019 -19% 01 Oct 2019 31 Dec 2019
Q3 2019 -19% 01 Jul 2019 30 Sep 2019

BioNexus Gene Lab Corp Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -17% +17% +49% 01 Jan 2024 31 Dec 2024
2023 -34% -29% -549% 01 Jan 2023 31 Dec 2023
2022 -5.3% -16% -149% 01 Jan 2022 31 Dec 2022
2021 11% -6.2% -36% 01 Jan 2021 31 Dec 2021
2020 17% +36% 01 Jan 2020 31 Dec 2020
2019 -19% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.